Wellbutrin Antitrust Cases Against GSK Dismissed

A federal judge has dismissed all claims against GlaxoSmithKline in the Wellbutrin XL antitrust litigation in which the pharmaceutical giant was accused of delaying the entry of generic versions of the antidepressant medication to market by entering into illegal agreements with generic drug makers to settle patent infringement lawsuits.

Read the original post:
Wellbutrin Antitrust Cases Against GSK Dismissed

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon
Sign Up For Our Email Newsletter

Over the years, through our many assignments, the Principals of Revitalization Partners frequently said to ourselves: “One day, we should write a book about our work and how we can help companies through our experiences.” This is that book and we hope that you find words of value to you and your business.

To Download Our
Corporate Capabilities Brochure